Abstract:To understand the potential role of cyclooxygenase (COX) in normal and inflammatory human diseases, we characterized the expression of COX-1 and COX-2 in biopsies of osteoarthritis, atherosclerosis, and cancer. Tissues were prepared for immunohistochemistry by standard methods, and representative cases assayed via Western blot and quantitative RT-PCR. COX-2 was not detected in normal human tissues with few exceptions. Moderate to marked COX-2 was observed in the macula densa (MD) and thick ascending limb (TAL) in human fetal kidneys, but was not detected in neonatal and adult MD and TALs. Low level, constitutive COX-2 was detected in colonic epithelium, peribronchial glands, and pancreatic ductal epithelium. Low to moderate COX-2 was detected basally in the cortex, hippocampus, hypothalamus, and spinal cord, and in reproductive tissues during ovulation, implantation and labor. No COX-2 was detected in the existing vasculature in normal tissues, and was also not expressed throughout the ductus arteriosus. COX-2 was markedly induced in human tissues of osteoarthritis, atherosclerosis and cancer. COX-2 was prominently expressed in the synovium, fibrocartilage of osteophytes, and in the blood vessels in the osteoarthritic (OA) knee joint. COX-2 was also prominently detected in the macrophages/foam cells in atherosclerotic plaques, and in the endothelium overlying and immediately adjacent to the fibrofatty lesion. Moderate- to intense COX-2 expression was consistently observed in the inflammatory cells, neoplastic lesions, and blood vessels in all epithelial-derived human cancers studied. In contrast, COX-1 was relatively ubiquitously observed in both normal and pathophysiological conditions. These data collectively imply COX-2 plays an important role in mediating a variety of inflammatory diseases, and imply COX-2 inhibitors may be effective in the prevention and/or treatment of OA, heart disease, and epithelial cancers.

Integrated Pathways of COX-2 and Mtor: Roles in Cell Sensing and Alzheimer’s Disease

Integrated Pathways of COX-2 and mTOR: Roles in Cell Sensing and Alzheimer's Disease.

Cyclo-Oxygenase 2 Up-Regulates the Effect of Multidrug Resistance

Integrated Communications Between Cyclooxygenase‐2 and Alzheimer's Disease

Exploring the Role of COX-2 in Alzheimer's Disease: Potential Therapeutic Implications of COX-2 inhibitors

[COX Plays a Pivotal Role in the Progressive Neuronal Loss in Neurodegenerative Diseases].

Aggravation of Alzheimer's disease due to the COX-2-mediated reciprocal regulation of IL-1β and Aβ between glial and neuron cells.

Quantification of COX-2 Level in Alzheimer's Disease Patients to Develop Potential Blood-Based Biomarker for Early Diagnosis and Therapeutic Target

Network based identification of Potential Key Genes associated with Alzheimer’s disease and Type 2 Diabetes using mTOR signalling

Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development

Cerebral Mtor Signal and Pro-Inflammatory Cytokines in Alzheimer's Disease Rats.

Cyclooxygenase-2 is Essential for Mediating the Effects of Calcium Ions on Stimulating Phosphorylation of Tau at the Sites of Ser 396 and Ser 404

Targeting the Mtor Signaling Network for Alzheimer'S Disease Therapy

Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity.

[Cyclooxygenases, Lipoxygenases, Their Targeted Drugs and the Prevention of Alzheimer's Disease].

Genetic model of selective COX2 inhibition improve learning and memory ability and brain pathological changes in 5xFAD mouse

Cyclooxygenase-2 in human pathological disease

Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process

Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxins 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer's Disease

Functional Analyses of Major Cancer-Related Signaling Pathways in Alzheimer's Disease Etiology.

Pharmacological mTOR inhibitors in ameliorating Alzheimer's disease: current review and perspectives